Pfizer, Sangamo announce updated results of phase 1/2 Alta study of giroctocogene fitelparvovec
These data are being presented today at the 62nd American Society for Hematology Annual meeting taking place virtually from December 5th – 8th. The oral presentation slides, which include follow-up